Scholarly publications and presentations by Rochester Regional Health's Research department authors.
Submissions from 2023
11-1-2023 Liver Abscesses Due to Fusobacterium nucleatum: A Case Series, Ahmed Elkhapery, Rochester Regional Health, Sheza Malik, Rochester Regional Health, Pratibha Chaudhary, Rochester Regional Health, et al.
11-1-2023 Variability of vaccine responsiveness in early life, Michael E. Pichichero, Rochester Regional Health
10-27-2023 A regulatory pathway model of neuropsychological disruption in Havana syndrome, Thomas P. Chacko, Rochester Regional Health, J Tory Toole, Rochester Regional Health, Matthew C. Morris, Rochester Regional Health, et al.
10-26-2023 Very early life microbiome and metabolome correlates with primary vaccination variability in children, Michael Shaffer, Exploratory Science Center, Merck & Co., Inc. , Cambridge, Massachusetts, USA., Katharine Best, Exploratory Science Center, Merck & Co., Inc. , Cambridge, Massachusetts, USA., Catherine Tang, Exploratory Science Center, Merck & Co., Inc. , Cambridge, Massachusetts, USA., et al.
8-1-2023 Expression conditions and characterization of a novelly constructed lipoprotein intended as a vaccine to prevent human Haemophilus influenzae infections, Ravinder Kaur, Rochester Regional Health, Jill Mangiafesto, Rochester Regional Health, Karin Pryharski, Rochester Regional Health, et al.
4-18-2023 Colonization, Density, and Antibiotic Resistance of Streptococcus pneumoniae, Haemophilus Influenzae, and Moraxella catarrhalis among PCV13-Vaccinated Infants in the First Six Months of Life in Rochester, New York: A Cohort Study, Ravinder Kaur, Rochester Regional Health and Michael Pichichero, Rochester Regional Health
2-1-2023 Vaccine target and carrier molecule nontypeable Haemophilus influenzae protein D dimerizes like the close Escherichia coli GlpQ homolog but unlike other known homolog dimers, Seth P. Jones, School of Chemistry and Materials Science, Rochester Institute of Technology, Rochester, New York, USA., Kali H. Cook, School of Chemistry and Materials Science, Rochester Institute of Technology, Rochester, New York, USA., Melody L. Holmquist, National Technical Institute for the Deaf, Rochester Institute of Technology, Rochester, New York, USA., et al.
2-1-2023 Window of Susceptibility to Acute Otitis Media Infection, Peter Bajorski, School of Mathematical Sciences, College of Science, Rochester Institute of Technology, Rochester, New York., Naoko Fuji, Rochester Regional Health, Ravinder Kaur, Rochester Regional Health, et al.
1-1-2023 Acute otitis media pneumococcal disease burden and nasopharyngeal colonization in children due to serotypes included and not included in current and new pneumococcal conjugate vaccines, Michael Pichichero, Rochester Regional Health, Richard Malley, Boston Children's Hospital, Division of Infectious Diseases, Boston Massachusetts, Ravinder Kaur, Rochester Regional Health, et al.
Submissions from 2022
12-1-2022 Haemophilus influenzae Protein D antibody suppression in a multi-component vaccine formulation, Lea V. Michel, School of Chemistry and Materials Science, Rochester Institute of Technology, NY, USA., Ravinder Kaur, Rochester Regional Health, Michael L. Gleghorn, School of Chemistry and Materials Science, Rochester Institute of Technology, NY, USA., et al.
12-2022 Refinement of Biological Regulatory Graphs using Functional Enrichment, Jeffrey M. Page, Rochester Regional Health, Matthew C. Morris, Rochester Regional Health, Gary Skuse, Rochester Regional Health, et al.
10-19-2022 Pathogenesis of Streptococcus pneumoniae serotype 3 during natural colonization and infections among children and its IgG correlate of protection in a mouse model, Naoko Fuji, Rochester Regional Health; Michael Pichichero, Rochester Regional Health; and Ravinder Kaur, Rochester Regional Health
10-10-2022 Old drugs, new tricks: leveraging known compounds to disrupt coronavirus-induced cytokine storm, Spencer Richman, Rochester Regional Health, Cole Lyman, Rochester Regional Health, Anastasia Nesterova, Elsevier BV, Biology Solutions, Amsterdam, the Netherlands., et al.
10-1-2022 Developing patient-centered outcomes research infrastructure in a rural community through patient and stakeholder engagement and education during the COVID-19 pandemic, Carly Lovelett, Rochester Regional Health, Michelle Medeiros, The PATIENTS Program, University of Maryland School of Pharmacy, Baltimore, MD, USA., Daniel Jaremczuk, Rochester Regional Health, et al.
7-26-2022 Mapping the network biology of metabolic response to stress in posttraumatic stress disorder and obesity, Thomas P. Chacko, Rochester Regional Health, J Tory Toole, Rochester Regional Health, Spencer Richman, Rochester Regional Health, et al.
7-12-2022 Network Modeling of Complex Time-Dependent Changes in Patient Adherence to Adjuvant Endocrine Treatment in ER+ Breast Cancer, Eileen H. Shinn, The University of Texas MD Anderson Cancer Center, Houston, TX, Brooke E. Busch, The University of Texas MD Anderson Cancer Center, Houston, TX, Neda Jasemi, The University of Texas MD Anderson Cancer Center, Houston, TX, et al.
5-19-2022 Lipidation of Haemophilus influenzae Antigens P6 and OMP26 Improves Immunogenicity and Protection against Nasopharyngeal Colonization and Ear Infection, Ravinder Kaur, Rochester Regional Health and Michael E. Pichichero, Rochester Regional Health
5-1-2022 Antibiotic Use and Vaccine Antibody Levels, Timothy J. Chapman, Rochester Regional Health, Minh Pham, School of Mathematical Sciences, College of Science, Rochester Institute of Technology, Rochester, New York., Peter Bajorski, School of Mathematical Sciences, College of Science, Rochester Institute of Technology, Rochester, New York., et al.
5-1-2022 Harnessing the Proteome in COPD to Identify Individuals Vulnerable to Frequent Exacerbations, S Sethi, University at Buffalo, Matthew Morris, Rochester Regional Health, Spencer Richman, Rochester Regional Health, et al.
5-1-2022 Identification of Novel Biomarkers for COPD Phenotypes by Large-Scale Proteomics Analysis with UHR-IonStar, S Sethi, University at Buffalo, X Zhu, University at Buffalo, S Shen, University at Buffalo, et al.
5-2022 Probing the potential interactions between two protein vaccine candidates from Nontypeable Haemophilus influenzae, Grace McGinnity, Rochester Institute of Technology, Rochester, NY., Janai Perdue, Rochester Institute of Technology, Rochester, NY., Natalie Labbe, Rochester Institute of Technology, Rochester, NY., et al.
5-1-2022 Proteomic Network Analysis of Bronchoalveolar Lavage Fluid in Ex-Smokers to Discover Implicated Protein Targets and Novel Drug Treatments for Chronic Obstructive Pulmonary Disease, Manoj J. Mammen, Department of Medicine, School of Medicine and Dentistry, University of Rochester, Rochester, NY 14642, USA., Chengjian Tu, Department of Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, NY 14260, USA., Matthew C. Morris, Rochester Regional Health, et al.
3-1-2022 Interferon-γ promotes monocyte-mediated lung injury during influenza infection, Taylor Schmit, University of North Dakota, Grand Forks, ND; Kai Guo, University of Michigan, Ann Arbor, MI; and Michael E. Pichichero, Rochester Regional Health
2-5-2022 Randomized Mechlorethamine/Chlormethine Induced Dermatitis Assessment Study (MIDAS) Establishes Benefit of Topical Triamcinolone 0.1% Ointment Cotreatment in Mycosis Fungoides, Carolina V. Alexander-Savino, Rochester Skin Lymphoma Medical Group, 6800 Pittsford Palmyra Rd, Suite 150, Fairport, NY, 14450, USA., Catherine G. Chung, Dermatology and Pathology, The Ohio State University, Columbus, OH, 43210, USA., Elaine S. Gilmore, Rochester Skin Lymphoma Medical Group, 6800 Pittsford Palmyra Rd, Suite 150, Fairport, NY, 14450, USA., et al.
2-2-2022 Computational prediction of intracellular targets of wild-type or mutant vesicular stomatitis matrix protein, Matthew C. Morris, Rochester Regional Health, Thomas M. Russell, Thomas Gosnell School of Life Sciences, Rochester Institute of Technology, Rochester, NY, United States of America., Cole A. Lyman, Rochester Regional Health, et al.